*Refresh the page if the below document does not appear.
In response to a PIL filed by the Karnataka Drugs and Pharmaceuticals Association and a few pharmaceutical companies, the high court ordered the issuance of notice to the Centre (finance ministry)
Indian Patent Office has approved a patent application submitted by Hyderabad-based biotechnology company Bharat Biotech International Ltd for its single dose conjugate vaccine Typbar-TCV, for the prevention of typhoid fever.
Amylyx Pharma announced that the US Food and Drug Administration (USFDA) had approved its drug for slowing the progression of ALS, or amyotrophic lateral sclerosis, and possibly postponing death.
The appointment of Vibha Paul Rishi to the board of directors of Piramal Pharma Limited (PPL) has been made public. An expert in marketing, Vibha has held global leadership positions in branding, strategy, innovation, and human resources.
Over the forecast period FY’2022-27, the Indian Rapid IVD kits market is predicted to expand at a steady rate with a CAGR of 19.9%. The demand for point-of-care diagnostics is rising, and this demand is being fueled by rapidly advancing technology.
Following the company’s receipt of USFDA approval for Mirabegron Tablets or Generic Myrbetrig, Lupin’s share price increased by nearly 4.5% to Rs 682 per share levels on the BSE and NSE intraday, respectively, during Friday’s trading session.
According to Intercept Pharmaceuticals, a
late-stage study’s primary objective was not
achieved by its treatment for patients with
advanced liver scarring brought on by nonalcoholic steatohepatitis (NASH).
If you don’t already have an account click the button below to create your account.Create New Account